BI Asset Management Fondsmaeglerselskab A S Sells 2,107 Shares of Humana Inc. $HUM

BI Asset Management Fondsmaeglerselskab A S cut its position in Humana Inc. (NYSE:HUM) by 33.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,144 shares of the insurance provider’s stock after selling 2,107 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Humana were worth $719,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Long Focus Capital Management LLC bought a new position in Humana in the 3rd quarter worth approximately $34,212,000. Aberdeen Group plc boosted its position in shares of Humana by 18.1% in the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after acquiring an additional 43,442 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Humana by 4.1% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after acquiring an additional 9,960 shares during the last quarter. Ninety One UK Ltd increased its position in Humana by 57.2% during the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after acquiring an additional 40,958 shares during the period. Finally, Sustainable Insight Capital Management LLC increased its position in Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after acquiring an additional 4,740 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on HUM. William Blair started coverage on shares of Humana in a report on Wednesday, May 20th. They issued an “outperform” rating for the company. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Bank of America increased their target price on shares of Humana from $340.00 to $380.00 and gave the company a “neutral” rating in a research note on Wednesday. Seaport Research Partners downgraded Humana to a “neutral” rating in a research report on Wednesday, May 20th. Finally, The Goldman Sachs Group upped their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus price target of $293.09.

Humana Price Performance

Shares of Humana stock opened at $375.45 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The firm’s 50-day simple moving average is $299.39 and its 200-day simple moving average is $244.75. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $380.86. The firm has a market cap of $45.08 billion, a P/E ratio of 40.16, a price-to-earnings-growth ratio of 2.06 and a beta of 0.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts expect that Humana Inc. will post 9.04 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.